Business, energy, technology, markets and global industry news from Business News Today

antimicrobial resistance

PharmaDeviceNews antimicrobial resistance
Precisio Biotix’s ClyO therapy is being evaluated for a chronic multidrug-resistant prosthetic joint infection, highlighting the search for new treatments against persistent implant-related bacterial infections. Representative image.
Pharma & Biotech

Precisio Biotix begins extended ClyO treatment for chronic prosthetic joint infection

Precisio Biotix reports early ClyO use in chronic prosthetic joint infection, highlighting its promise, evidence limits and regulatory hurdles.

Read More
Representative image: OM Pharma’s Broncho-Vaxom OM-85 real-world evidence study highlights growing clinical interest in respiratory tract infection prevention, non-antibiotic care strategies, and data-driven respiratory health research.
Pharma & Biotech

Could OM Pharma’s Broncho-Vaxom study change how clinicians assess recurrent RTI prevention?

Find out how OM Pharma’s Broncho-Vaxom data could reshape RTI prevention, real-world evidence and non-antibiotic care strategies.

Read More
Representative image of an intravenous antibiotic vial and sterile hospital laboratory setup, reflecting Wockhardt’s Zaynich FDA approval and India’s growing role in antimicrobial resistance innovation.
Pharma & Biotech

Can Zaynich help Wockhardt turn Indian antibiotic innovation into a global commercial platform?

Find out how Wockhardt’s Zaynich FDA approval could reshape Indian pharma innovation and the fight against drug-resistant infections.

Read More
Representative image: A laboratory professional reviews STI test samples and public health data as Europe’s record rise in gonorrhoea, syphilis and chlamydia cases puts diagnostics, prevention and antimicrobial resistance strategies under renewed scrutiny.
Medical Devices & Diagnostics

Can Europe contain its STI surge before antimicrobial resistance narrows treatment options?

Europe’s STI surge is testing diagnostics, prevention and treatment capacity as gonorrhoea and syphilis reach record levels.

Read More
Representative image: A clinical research laboratory setting illustrates Meiji Seika Pharma’s nacubactam Phase III progress, as the novel β-lactamase inhibitor advances the fight against complicated urinary tract infections, acute pyelonephritis and antimicrobial resistance.
Pharma & Biotech

Nacubactam trial win gives Meiji Seika Pharma a stronger AMR case, but approval hurdles remain

Antibiotic resistance needs new tools. Meiji Seika Pharma’s nacubactam now has Phase III data, but regulators must judge its real-world fit.

Read More
Bruker expands MALDI Biotyper workflows as microbiology labs push for faster outbreak detection
Medical Devices & Diagnostics

Why Bruker’s ESCMID 2026 microbiology expansion could matter for hospital labs and infection control

Bruker expanded its microbiology portfolio at ESCMID 2026. Read what the new MALDI and outbreak tools could mean for labs and infection control.

Read More
Pharma & Biotech

Can Vedanta Biosciences turn microbiome therapeutics into a real prevention strategy for recurrent CDI and resistant infections?

Vedanta Biosciences unveiled VE303 and VE707 data at ESCMID 2026. Read why the microbiome strategy matters for CDI and resistant infections.

Read More
Representative image of a rapid diagnostic system used in hospital laboratories, reflecting how Pattern Bioscience’s pneumonia ID AST panel aims to deliver faster phenotypic results for critically ill patients and improve antibiotic decision making in ICU settings.
Medical Devices & Diagnostics

Is culture-free pneumonia testing finally viable as Pattern Bioscience nears regulatory submission

Pattern Bioscience advances rapid pneumonia diagnostics toward FDA clearance. Discover what this means for ICU care and antibiotic resistance.

Read More
Thermo Fisher Scientific targets Candida auris with new chromogenic media
Medical Devices & Diagnostics

Faster Candida auris identification? Thermo Fisher Scientific unveils new agar

Thermo Fisher Scientific launches chromogenic media to detect Candida auris faster. Explore what this means for labs and AMR strategy.

Read More
Pharma & Biotech

Sinomune to launch Almirall’s Seysara in China: Can it reshape acne treatment models?

Almirall’s Seysara gains NMPA approval for acne in China. Find out what this means for dermatology antibiotics, access, and Sinomune’s market role.

Read More